Wedbush Securities’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Other funds holding UTHR
Wedbush Securities's UTHR Position: Q3 2026 in Review
Wedbush Securities reduced its United Therapeutics (UTHR) stake by 5.4% in Q3 2026, selling an estimated $23.3K and leaving 790 shares worth $428K. The position accounts for 0.01% of the portfolio, ranked #784.
Wedbush Securities first reported a position in UTHR in Q4 2016 and has held it in 16 quarters since. The position peaked at $549K in Q4 2017. 848 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.
- Wedbush Securities held 790 shares of United Therapeutics worth $428K as of Q3 2026.
- Wedbush Securities sold 45 United Therapeutics shares in Q3 2026, an estimated $23.3K.
- United Therapeutics made up 0.01% of Wedbush Securities's portfolio in Q3 2026, its #784 holding.
- Wedbush Securities first reported a position in United Therapeutics in Q4 2016 and has held it in 16 quarters since.
- Wedbush Securities's United Therapeutics position peaked at $549K in Q4 2017.
- 848 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.
Based on Wedbush Securities's 13F filing for Q3 2026, filed 22 Oct 2026.